DIVESH SARDANA

Assistant Professor in Pediatric Dentistry

Indiana State University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. Divesh Sardana is an Assistant Professor in Pediatric Dentistry at Indiana University Indianapolis, USA. His research focuses on pediatric dental health, with recent studies addressing topics such as dental education gaps in Uganda, the prevalence of dental fluorosis in India, and the effects of chemotherapy on children’s oral health. Dr. Sardana also explores innovative dental technologies and preventive measures in pediatric dentistry, aiming to enhance oral health care access and outcomes.

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Aim To conduct a systematic review and meta‐analysis of randomized controlled trials (RCTs) comparing the effectiveness of real‐time continuous glucose monitoring (rtCGM) versus intermittently scanned continuous glucose monitoring (isCGM) on key glycaemic metrics (co‐primary outcomes HbA1c and time‐in‐range [TIR] 70–180 mg/dL, 3.9–10.0 mmol/L) among people with type 1 diabetes (T1D). Methods Medline, PubMed, Scopus, Web of Science and Cochrane Central Register of clinical trials were searched. Inclusion criteria were RCTs; T1D populations of any age and insulin regimen; comparing any type of rtCGM with isCGM (only the first generation had been compared to date); and reporting the glycaemic outcomes. Glycaemic outcomes were extracted post‐intervention and expressed as mean differences and 95% CIs between the two comparators. Results were pooled using a random‐effect meta‐analysis. The risk of bias was assessed using the Cochrane RoB2 tool. The quality of evidence was assessed by the GRADE approach. Results Five RCTs met the inclusion criteria (4 parallel and 1 crossover design; 4 with CGM use <8 weeks), involving 446 participants (354 adults; 92 children and adolescents). Overall, meta‐analysis showed rtCGM compared to isCGM improved absolute TIR by +7.0% (95% CI: 5.8%–8.3%, I 2 = 0%, p < 0.01) accompanied by a favorable effect on time‐below‐range <70 mg/dL (3.9 mmol/L) – 1.7% (95%CI: −3.0% to −0.4%; p = 0.03). No differences were seen regarding HbA1c. Conclusions This meta‐analysis highlights that for people with T1D, rtCGM confers benefits over isCGM primarily related to increased TIR, with improvements in hypo‐ and hyperglycaemia.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Michelle Bass

University of Pennsylvania

UNITED STATES
View details

Allison Scully

Indiana University School of Dentistry

UNITED STATES
View details

Benjamin John Wheeler

-

NEW ZEALAND
View details

Aline Castilho

Assistant Professor

Indiana State University

UNITED STATES
View details

Manikandan Ekambaram

-

NEW ZEALAND
View details

Ram Bajpai

Keele University

UNITED KINGDOM
View details

Simin Peng

Clinical Assistant Professor

The University of Hong Kong

HONG KONG
View details

Timothy Fagan

Clinical Professor and Chair

University of Oklahoma Health Sciences Center

UNITED STATES
View details